Rochester Center for Behavioral Medicine
Quick facts
Marketed products
- Dyanavel XR · Psychiatry / Neurology
Dyanavel XR is an extended-release liquid formulation of amphetamine that increases the release of dopamine and norepinephrine in the central nervous system to improve attention and reduce hyperactivity. - Placebo "30, 50 or 70 mg" · Psychiatry/Behavioral Medicine
Placebo produces therapeutic effects through the patient's expectation and belief in treatment, activating endogenous neurobiological pathways independent of pharmacological action. - Solriamfetol Oral Tablet [Sunosi] · Neurology / Sleep Medicine
Solriamfetol is a dopamine and norepinephrine reuptake inhibitor that increases wakefulness by blocking the reuptake of these neurotransmitters in the central nervous system.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: